Ibod

Public sources located for this profile provide only limited, indirect information about IBOD Company, Inc. The clearest company-specific evidence is a warrant agreement filed with the U.S. Securities and Exchange Commission as Exhibit 4.3 to a Form S-1 registration statement (SEC CIK 1788882). That document identifies the issuer as "IBOD COMPANY, INC." and records a warrant to purchase 50,000 shares of Series A-3 Preferred Stock at $2.8714 per share, issued July 7, 2016 and expiring July 7, 2026, to Silicon Valley Bank in connection with a Loan and Security Agreement of the same date. The warrant provided for transfer to SVB Financial Group, allowed cashless exercise, and contained customary provisions governing treatment of the warrant in the event of an acquisition of the company.

No source in the material describes IBOD Company, Inc.'s products, customers, revenue model, headcount, or market position. The existence of a multi-series preferred stock structure (Series A-3) and a venture-debt facility from Silicon Valley Bank indicates a privately held, institutionally financed company as of 2016, and the S-1 filing context indicates the company was at some point preparing a registered securities offering. Several other documents retrieved share the "IBOD" string but relate to different entities and were excluded: the ITE International Board of Direction governance recap, IBOD Imaging, Inc. (formerly DOBI Medical, a New Jersey-based breast imaging company), the unrelated media and hosting site ibod.com, and IB Acquisition Corp., a Florida blank-check SPAC.